274 related articles for article (PubMed ID: 22633835)
1. The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Fragoso YD; Boggild M; Macias-Islas MA; Carra A; Schaerer KD; Aguayo A; de Almeida SM; Alvarenga MP; Alvarenga RM; Alves-Leon SV; Arruda WO; Brooks JB; Comini-Frota ER; Ferreira ML; Finkelsztejn A; Finkelsztejn JM; de Freitas LD; Gallina AS; da Gama PD; Georgetto S; Giacomo MC; Gomes S; Gonçalves MV; Grzesiuk AK; Kaimen-Maciel DR; Lopes J; Lourenco GA; Malfetano FR; Morales NM; Morales Rde R; Oliveira CL; Onaha P; Patroclo C; Ribeiro SB; Ribeiro TA; Salminen HJ; Santoro P; Seefeld M; Soares PV; Tarulla A; Vasconcelos CC
Clin Neurol Neurosurg; 2013 Feb; 115(2):154-9. PubMed ID: 22633835
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review.
Fragoso YD; Adoni T; Alves-Leon SV; Azambuja ND; Barreira AA; Brooks JB; Carneiro DS; Carvalho MJ; Claudino R; Comini-Frota ER; Domingues RB; Finkelzstejn A; Gama PD; Giacomo MC; Gomes S; Goncalves MV; Grzesiuk AK; Kaimen-Maciel DR; Mendes MF; Morales NM; Morales RR; Muniz A; Papais-Alvarenga RM; Parolin MK; Ribeiro SB; Ruocco HH; Siquineli F; Tosta ED
CNS Drugs; 2013 Nov; 27(11):955-61. PubMed ID: 24114585
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study.
Villaverde-González R; Candeliere-Merlicco A; Alonso-Frías MA; Aparicio Castro E; Carrillo Alcaraz A; Mallada Frechín J; Pérez Sempere Á
Mult Scler Relat Disord; 2020 Nov; 46():102518. PubMed ID: 32977075
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Cuello JP; Martínez Ginés ML; Martin Barriga ML; de Andrés C
Neurologia; 2017 Mar; 32(2):92-98. PubMed ID: 25728948
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).
Fernández Liguori N; Klajn D; Acion L; Cáceres F; Calle A; Carrá A; Cristiano E; Deri N; Garcea O; Jaureguiberry A; Onaha P; Patrucco L; Riccio P; Rotta Escalante R; Saladino Ml; Sinay V; Tarulla A; Villa A
Mult Scler; 2009 May; 15(5):555-62. PubMed ID: 19299437
[TBL] [Abstract][Full Text] [Related]
6. [Disease modifying drugs in multiple sclerosis and pregnancy].
Tur C; Tintoré M; Aguilera C
Med Clin (Barc); 2012 Sep; 139(7):316-8. PubMed ID: 22743277
[No Abstract] [Full Text] [Related]
7. Glatiramer acetate during early pregnancy: A prospective cohort study.
Herbstritt S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
Mult Scler; 2016 May; 22(6):810-6. PubMed ID: 26754804
[TBL] [Abstract][Full Text] [Related]
8. Use and safety of disease-modifying therapy in pregnant women with multiple sclerosis.
MacDonald SC; McElrath TF; Hernández-Díaz S
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):556-560. PubMed ID: 30834654
[TBL] [Abstract][Full Text] [Related]
9. Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.
Amato MP; Portaccio E
CNS Drugs; 2015 Mar; 29(3):207-20. PubMed ID: 25773609
[TBL] [Abstract][Full Text] [Related]
10. Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs.
Lu E; Dahlgren L; Sadovnick A; Sayao A; Synnes A; Tremlett H
Mult Scler; 2012 Apr; 18(4):460-7. PubMed ID: 21914689
[TBL] [Abstract][Full Text] [Related]
11. The Brazilian database on pregnancy in multiple sclerosis.
Finkelsztejn A; Fragoso YD; Ferreira ML; Lana-Peixoto MA; Alves-Leon SV; Gomes S; Damasceno BP; Mendes MF; Salgado PR; Correa EC; Comini-Frota ER; Diniz DS; Gama PD; Kaimen-Maciel DR; Morales RR; Arruda WO; Grzesiuk AK; Khouri JM; Lopes JS; Rocha CF; Domingues R; Gonçalves MV; Lorenti MA; Parolin MK; Siquineli F; Tosta ED; Brooks JB; Gallina AS; Melges LD; Ruocco HH
Clin Neurol Neurosurg; 2011 May; 113(4):277-80. PubMed ID: 21159421
[TBL] [Abstract][Full Text] [Related]
12. Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
Lu E; Wang BW; Guimond C; Synnes A; Sadovnick D; Tremlett H
Neurology; 2012 Sep; 79(11):1130-5. PubMed ID: 22933738
[TBL] [Abstract][Full Text] [Related]
13. [Pregnancy and multiple sclerosis -outcomes analysis 2003-2011].
Hanulíková P; Vlk R; Meluzínová E; Hynčicová E; Binder T; Chmel R; Rob L
Ceska Gynekol; 2013 Apr; 78(2):142-8. PubMed ID: 23710978
[TBL] [Abstract][Full Text] [Related]
14. An overview of pregnancy-related issues in patients with multiple sclerosis.
Pozzilli C; Pugliatti M;
Eur J Neurol; 2015 Oct; 22 Suppl 2():34-9. PubMed ID: 26374512
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: management issues during pregnancy.
Ferrero S; Pretta S; Ragni N
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):3-9. PubMed ID: 15223156
[TBL] [Abstract][Full Text] [Related]
16. [A possible effect of the immunomodulating therapy with beta-interferons and glatimer acetate on the development of thyroid disease in patients with multiple sclerosis].
Petrova LV; Boĭkova AN; Batysheva TT; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):58-67. PubMed ID: 21916158
[TBL] [Abstract][Full Text] [Related]
17. Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants.
Bove R; Hellwig K; Pasquarelli N; Borriello F; Dobson R; Oreja-Guevara C; Lin CJ; Zecevic D; Craveiro L; McElrath T; Vukusic S
Mult Scler Relat Disord; 2022 Aug; 64():103963. PubMed ID: 35753176
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series.
Fragoso YD; Finkelsztejn A; Kaimen-Maciel DR; Grzesiuk AK; Gallina AS; Lopes J; Morales NM; Alves-Leon SV; de Almeida SM
CNS Drugs; 2010 Nov; 24(11):969-76. PubMed ID: 20806993
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcomes in Portuguese women with multiple sclerosis: The PREGNIMS study.
Novo A; Castelo J; de Sousa A; Amorim I; Alves JN; Calejo M; Monteiro A; Arenga M; Shamasna M; Vale J; Sá MJ; Palavra F
Mult Scler Relat Disord; 2019 Feb; 28():172-176. PubMed ID: 30611102
[TBL] [Abstract][Full Text] [Related]
20. Therapy Optimization in Multiple Sclerosis: a cohort study of therapy adherence and risk of relapse.
Cohen BA; Coyle PK; Leist T; Oleen-Burkey MA; Schwartz M; Zwibel H
Mult Scler Relat Disord; 2015 Jan; 4(1):75-82. PubMed ID: 25787057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
